ClinConnect ClinConnect Logo
Search / Trial NCT06235372

Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease

Launched by ASSIUT UNIVERSITY · Jan 30, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how thyroid eye disease affects the cells in the cornea, which is the clear front part of the eye. Researchers want to see if there is any damage to the corneal endothelial cell layer in patients with this condition. The study will use a special imaging technique called specular microscopy to take a closer look at these cells.

To participate in this trial, individuals must have been diagnosed with thyroid eye disease based on specific medical criteria. However, people with other serious health issues, such as diabetes, or those who have had prior eye surgeries, corneal diseases, eye injuries, or glaucoma, will not be eligible. The trial is currently not recruiting participants, and it aims to gather important information that could help improve the understanding and treatment of thyroid eye disease in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with thyroid eye disease whom diagnosis was established based on bartley diagnostic criteria .
  • Exclusion Criteria:
  • participates with systemic diseases other than HT such as
  • 1. diabetes mellitus
  • 2. previous ocular surgery or laser therapy.
  • 3. history of corneal disease.
  • 4. history of trauma.
  • 5. history of glaucoma

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Dalia Mohammed, Professor

Study Director

Academic organizations

Khaled Abdelazim, Assistant professor

Study Director

Academic organizations

Ahmed Abdelnasser, Lecturer

Study Director

Academic organizations

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported